According to Horizon Therapeutics
's latest financial reports the company has $5.31 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $5.07 B | 8.56% |
2021-12-31 | $4.67 B | 16.07% |
2020-12-31 | $4.02 B | 84.19% |
2019-12-31 | $2.18 B | 107.32% |
2018-12-31 | $1.05 B | 6.36% |
2017-12-31 | $0.99 B | -21.58% |
2016-12-31 | $1.26 B | -3.76% |
2015-12-31 | $1.31 B | 143.08% |
2014-12-31 | $0.54 B | -1200.62% |
2013-12-31 | $-49.09 M | -146.31% |
2012-12-31 | $0.10 B | 130.83% |
2011-12-31 | $45.91 M | -52.7% |
2010-12-31 | $97.05 M | -3154.96% |
2009-12-31 | $-3.18 M | -62.42% |
2008-12-31 | $-8.46 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $89.28 B | 1,581.20% | ๐บ๐ธ USA |
Amgen AMGN | $6.23 B | 17.34% | ๐บ๐ธ USA |
Merck MRK | $37.63 B | 608.63% | ๐บ๐ธ USA |
AstraZeneca AZN | $39.16 B | 637.46% | ๐ฌ๐ง UK |
Dr. Reddy's RDY | $3.21 B | -39.42% | ๐ฎ๐ณ India |